145 related articles for article (PubMed ID: 1679625)
1. [Quinazolinones. 18. Synthesis and H1/H2-antihistaminic action of omega-[2-aryl-2,3-dihydro-4(1H)-quinazolinone-1-yl]alkyl substituted ureas and cyanoguanidines].
Büyüktimkin S; Buschauer A; Schunack W
Arch Pharm (Weinheim); 1991 May; 324(5):291-5. PubMed ID: 1679625
[TBL] [Abstract][Full Text] [Related]
2. [Quinazolinones. 16. Synthesis and in vitro pharmacology of 2-aryl-1- ([3-(imidazol-4-yl)propyl]-guanidinylalkyl)-2,3-dihydro-4(1H)- quinazolinones].
Büyüktimkin S; Buschauer A; Schunack W
Arch Pharm (Weinheim); 1989 Feb; 322(2):115-8. PubMed ID: 2567156
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 3-[2-(2,3-dihydro-5-phenyl-4-substituted-3H-1,2,4- triazole-3-thione-2-yl)-acetylamino]-2-methyl-4(3H)-quinazolinones and their pharmacological activities.
Büyüktimkin S; Büyüktimkin N; Ozdemir O; Rollas S
Arch Pharm (Weinheim); 1989 Jan; 322(1):49-51. PubMed ID: 2567155
[TBL] [Abstract][Full Text] [Related]
4. [Synthesis and H2-antihistaminic effect of N,N'-bisheteroaryl N,N'-bisheteroaryl-substituted cyanoguanidines and 2-nitro-1,1-ethenediamines. 17. H2-antihistaminics].
Borchers A; Postius S; Szelenyi I; Schunack W
Arzneimittelforschung; 1984; 34(7):751-4. PubMed ID: 6149751
[TBL] [Abstract][Full Text] [Related]
5. [Synthesis and combined H1-/H2 antagonist activity of mepyramine, pheniramine and cyclizine derivatives with cyanoguanidine, urea and nitroethenediamine partial structures].
Schulze FR; Alisch RA; Buschauer A; Schunack W
Arch Pharm (Weinheim); 1994 Jul; 327(7):455-62. PubMed ID: 7915515
[TBL] [Abstract][Full Text] [Related]
6. Iodoaminopotentidine and related compounds: a new class of ligands with high affinity and selectivity for the histamine H2 receptor.
Hirschfeld J; Buschauer A; Elz S; Schunack W; Ruat M; Traiffort E; Schwartz JC
J Med Chem; 1992 Jun; 35(12):2231-8. PubMed ID: 1613748
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and dual histamine H₁ and H₂ receptor antagonist activity of cyanoguanidine derivatives.
Sadek B; Alisch R; Buschauer A; Elz S
Molecules; 2013 Nov; 18(11):14186-202. PubMed ID: 24248146
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and pharmacology of combined histamine H1-/H2-receptor antagonists containing diphenhydramine and cyproheptadine derivatives.
Wolf C; Schunack W
Arch Pharm (Weinheim); 1996 Feb; 329(2):87-94. PubMed ID: 8851472
[TBL] [Abstract][Full Text] [Related]
9. [Guanidinothiazoles with H2-antihistaminic activity. 12: H2-antihistamines].
Trumm KA; Schunack W
Arzneimittelforschung; 1983; 33(2):188-90. PubMed ID: 6133522
[TBL] [Abstract][Full Text] [Related]
10. [Synthesis and pharmacologic action of substituted imidazolyl- and thiazolylmethylthioethylguanidine].
Buschauer A
Arzneimittelforschung; 1987 Sep; 37(9):1003-7. PubMed ID: 2893625
[TBL] [Abstract][Full Text] [Related]
11. Combined histamine H1/H2 receptor antagonists: part I. Pharmacological hybrids with pheniramine- and roxatidine-like substructures.
Schulze FR; Buschauer A; Schunack W
Eur J Pharm Sci; 1998 Jul; 6(3):177-86. PubMed ID: 9795048
[TBL] [Abstract][Full Text] [Related]
12. 4-(4-Guanidinobenzoyl)-2-imidazolones and related compounds: phosphodiesterase inhibitors and novel cardiotonics with combined histamine H2 receptor agonist and PDE III inhibitor activity.
Glass D; Buschauer A; Tenor H; Bartel S; Will-Shahab L; Krause EG
Arch Pharm (Weinheim); 1995 Oct; 328(10):709-19. PubMed ID: 8554460
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs.
Buschauer A
J Med Chem; 1989 Aug; 32(8):1963-70. PubMed ID: 2569042
[TBL] [Abstract][Full Text] [Related]
14. [Synthesis and h2-antihistaminic activity of n,n'-bisimidazole-substituted thioureas, cyanoguanidines and 2-nitro-1,1-ethenediamines 10. C: H2-antihistaminics].
Borchers A; Engler H; Szelenyi I; Schunack W
Arzneimittelforschung; 1982; 32(12):1509-12. PubMed ID: 6130774
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiulcer activity of N-substituted N'-[3-[3-(piperidinomethyl)phenoxy]propyl]ureas: histamine H2-receptor antagonists with a potent mucosal protective activity.
Miyashita M; Matsumoto T; Matsukubo H; Iinuma F; Taga F; Sekiguchi H; Hamada K; Okamura K; Nishino K
J Med Chem; 1992 Jun; 35(13):2446-51. PubMed ID: 1352351
[TBL] [Abstract][Full Text] [Related]
16. [Impromidine-analogous guanidines: synthesis and activity at the histamine H2-receptor. 29. Histamine analogs].
Elz S; Schunack W
Arzneimittelforschung; 1988 Mar; 38(3):327-32. PubMed ID: 2898245
[TBL] [Abstract][Full Text] [Related]
17. [H2-antihistaminics, VII: Synthesis and H2-antihistaminic activity of N,N'-substituted thioureas, cyanoguanidines and dithiooxamides (author's transl)].
Barzen R; Schunack W
Arch Pharm (Weinheim); 1981 Jul; 314(7):617-22. PubMed ID: 6117264
[No Abstract] [Full Text] [Related]
18. Combined histamine H1/H2 receptor antagonists: part II. Pharmacological hybrids with pheniramine- and tiotidine-like substructures.
Wolf C; Schulze FR; Buschauer A; Schunack W
Eur J Pharm Sci; 1998 Jul; 6(3):187-96. PubMed ID: 9795053
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and histamine H2-receptor antagonist activity of 4-(1-pyrazolyl)butanamides, guanidinopyrazoles, and related compounds.
Buschauer A; Mohr R; Schunack W
Arch Pharm (Weinheim); 1995 Apr; 328(4):349-58. PubMed ID: 7611832
[TBL] [Abstract][Full Text] [Related]
20. [Synthesis and pharmacologic action of arylmethylethylguanidines].
Buschauer A
Arzneimittelforschung; 1987 Sep; 37(9):1008-12. PubMed ID: 2893626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
